Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BCG-vaccinated cattle less infectious to other cattle, study finds
The UK government is currently conducting its own research into a deployable vaccine for cattle.
Study in Ethiopia suggests elimination of bovine TB in country is possible.

TB-infected cattle that have previously been given the Bacillus Calmette-Guérin (BCG) vaccine are less infectious to other cattle, a new study has found.
 
The research, led by the University of Cambridge and Penn State University, found that the BCG vaccine reduced TB transmission between cattle by 74 per cent per cent.

It is the first time this indirect benefit of the vaccine has been measured by scientists.

Conducted in Ethiopia, the study made use of livestock census and movement data to develop a transmission model.

Ethopia has the largest cattle population in Africa, but currently lacks a control programme for bovine TB. Intensive testing and slaughtering infected animals, as carried out in countries such as the UK, is considered to be unfeasible to implement in Ethiopia and other similar countries due to social and economic reasons.

Professor Conlan, associate professor of epidemiology at the University of Cambridge's Department of Veterinary Medicine and one of the authors of the study, said: "Results of the model suggest that vaccinating calves within the dairy sector of Ethiopia could reduce the reproduction number of the bacterium -- the R0 -- to below 1, arresting the projected increase in the burden of disease and putting herds on a pathway towards elimination of TB.”

The UK government is currently conducting its own research into creating a deployable vaccine and new DIVA skin test for bovine TB. Currently, the UK does not use the BCG vaccine because it can lead to vaccinated cattle giving false positive test results.

James Wood, Alborada professor of equine and farm animal science at the University of Cambridge's Department of Veterinary Medicine, said: "For over twenty years the UK government has pinned hopes on cattle vaccination for bovine tuberculosis as a solution to reduce the disease and the consequent costs of the controls.

“These results provide important support for the epidemiological benefit that cattle vaccination could have to reduce rates of transmission to and within herds."

The study has been published in the journal Science.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.